-
Bill Gates Reflects On Nelson Mandela's Efforts: 'Global Health Stands On The Shoulders Of His Immense Legacy'
Tuesday, July 18, 2023 - 11:23pm | 491In a recent tweet, tech mogul Bill Gates reflected on the significant impact made by Nelson Mandela in the fight against apartheid and HIV/AIDS. What Happened: Gates expressed admiration for the African leader’s contributions to society with the tweet: “Today, I’m reflecting on...
-
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
Friday, December 2, 2022 - 7:01am | 1216Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year trail 2021’s tally by about 35%. The two NMEs that were okayed in November include Provention Bio, Inc.’s...
-
Mylan Price Target Slashed Even As TLD Drug Receives Tentative Approval
Monday, August 7, 2017 - 11:56am | 505Morgan Stanley reduced its price target on the shares of Mylan N.V. (NASDAQ: MYL) following downward revision to its estimates due to the IMS trends, generic price pressure and uncertain new launch timing. Meanwhile, in a separate note, Mylan announced its NDA for TLD, a combo of Lamivudhine...
-
Getting Into The Business Of Medical Marijuana: An Interview With IGC CEO Ram Mukunda
Wednesday, March 15, 2017 - 7:47am | 1143Engineering graduate Ram Mukunda spent more than 25 years working in Wall Street. He served in companies communications firms Intelsat SA (NYSE: I) and Startec, before making an incursion into the mining industry through a company he co-founded. India Globalization Capital, Inc. (NYSE: IGC) was...
-
New Potential HIV Vaccine Drug 'Absolutely 100% Effective' In Monkeys
Friday, February 20, 2015 - 8:22am | 473According to a recent article in Nature, an experimental drug being tested at the Scripps Research Institute in Florida has been effective in blocking HIV infection in monkeys. The new drug has yet to be tested on humans, but preliminary results in animal testing have researchers excited about...
-
Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech Stocks
Wednesday, June 18, 2014 - 9:38am | 768This month marks 33 years since the U.S. Centers for Disease Control and Prevention (CDC) reported on a rare lung infection affecting a group of gay men – one of the first known medical mentions of what later became known as the AIDS outbreak. The World Health Organization says that, over...